Sanofi and Regeneron rheumatoid arthritis drug meets goals in Phase 3 trial
Rheumatoid arthritis is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Arthritis | Autoimmune Disease | Biotechnology | Pharmaceuticals | Rheumatoid Arthritis | Rheumatology